PTGS2 and cancer: Therefore, COX-2/PGE2 axis activation by CTX-treated cancer cells is a prevalent phenomenon conserved in mice and humans, which occurs irrespective of the tissue of origin and antineoplastic agent used, but is reliant on baseline cancer cell expression of COX-2 and sensitivity to drug treatment.